03/27/2024 3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/27/2024 3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/26/2024 8:16 AM | Acumen Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:05 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:32 AM | Acumen Pharmaceuticals (Subject) Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/06/2024 8:02 AM | Acumen Pharmaceuticals (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G | |
|
02/01/2024 4:01 PM | Acumen Pharmaceuticals (Issuer) Doherty James J. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/01/2024 4:02 PM | Acumen Pharmaceuticals (Issuer) Doherty James J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:16 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 3:22 PM | Acumen Pharmaceuticals (Subject) MURRAY JAMES B JR (Filed by)
| Form SC 13G/A | |
01/19/2024 6:04 PM | Acumen Pharmaceuticals (Issuer) Barton Russell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:05 PM | Acumen Pharmaceuticals (Issuer) Siemers Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:05 PM | Acumen Pharmaceuticals (Issuer) Zuga Matt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:06 PM | Acumen Pharmaceuticals (Issuer) Meisner Derek M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:07 PM | Acumen Pharmaceuticals (Issuer) OConnell Daniel Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:35 PM | Acumen Pharmaceuticals (Subject) OConnell Daniel Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:36 PM | Acumen Pharmaceuticals (Subject) Meisner Derek M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:27 PM | Acumen Pharmaceuticals (Subject) Zuga Matt (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:28 PM | Acumen Pharmaceuticals (Subject) Barton Russell (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:29 PM | Acumen Pharmaceuticals (Subject) Siemers Eric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 7:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:20 PM | Acumen Pharmaceuticals (Issuer) Zuga Matt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:21 PM | Acumen Pharmaceuticals (Issuer) Siemers Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:22 PM | Acumen Pharmaceuticals (Issuer) Meisner Derek M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:23 PM | Acumen Pharmaceuticals (Issuer) Barton Russell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:18 PM | Acumen Pharmaceuticals (Issuer) OConnell Daniel Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 6:45 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:20 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/18/2023 5:31 PM | Acumen Pharmaceuticals (Issuer) Ives Jeffrey L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 10:46 AM | Acumen Pharmaceuticals (Subject) Ives Jeffrey L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023 6:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 3:49 PM | Acumen Pharmaceuticals (Filer)
| Form 424B5 | |
07/17/2023 3:44 PM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 5:06 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 3:21 PM | Acumen Pharmaceuticals (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 4:40 PM | Acumen Pharmaceuticals (Issuer) Drapkin Kimberlee C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 4:42 PM | Acumen Pharmaceuticals (Issuer) Fountain Nathan B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 4:43 PM | Acumen Pharmaceuticals (Issuer) Ives Jeffrey L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 4:43 PM | Acumen Pharmaceuticals (Issuer) Porter Derrell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
06/07/2023 4:44 PM | Acumen Pharmaceuticals (Issuer) Stoppel Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 4:45 PM | Acumen Pharmaceuticals (Issuer) Stalfort John A III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2023 6:08 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/27/2023 3:26 PM | Acumen Pharmaceuticals (Filer)
| Form ARS | |
04/27/2023 6:02 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/27/2023 6:06 AM | Acumen Pharmaceuticals (Filer)
| Form 424B5 | |
04/14/2023 3:33 PM | Acumen Pharmaceuticals (Filer)
| Form PRE 14A | |
03/28/2023 3:20 PM | Acumen Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |